BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24824291)

  • 1. Relationship of coagulation and fibrinolytic variables with arterial structure and function in Africans.
    Pieters M; Boshuizen H; de Lange Z; Schutte AE; Schutte R; Greeff M; Ariëns RA
    Thromb Res; 2014 Jul; 134(1):78-83. PubMed ID: 24824291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans.
    Pieters M; Kotze RC; Jerling JC; Kruger A; Ariëns RA
    Blood; 2013 Apr; 121(16):3254-60. PubMed ID: 23422752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine influences blood clot properties alone and in combination with total fibrinogen but not with fibrinogen γ' in Africans.
    Nienaber-Rousseau C; de Lange Z; Pieters M
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):389-95. PubMed ID: 25688462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CVD risk factors are related to plasma fibrin clot properties independent of total and or γ' fibrinogen concentration.
    Kotzé RC; Ariëns RA; de Lange Z; Pieters M
    Thromb Res; 2014 Nov; 134(5):963-9. PubMed ID: 25213709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults.
    Eksteen P; Pieters M; de Lange Z; Kruger HS
    Thromb Res; 2015 Aug; 136(2):415-21. PubMed ID: 26070447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time.
    de Lange Z; Rijken DC; Hoekstra T; Conradie KR; Jerling JC; Pieters M
    PLoS One; 2013; 8(12):e83151. PubMed ID: 24386152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the metabolic syndrome with PAI 1
    Swanepoel AC; van Reenen M; de Lange-Loots Z; Pieters M
    Nutr Metab Cardiovasc Dis; 2023 Mar; 33(3):592-601. PubMed ID: 36646603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma clot lysis time and its association with cardiovascular risk factors in black Africans.
    de Lange Z; Pieters M; Jerling JC; Kruger A; Rijken DC
    PLoS One; 2012; 7(11):e48881. PubMed ID: 23145007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
    Cantero M; Rojas H; Anglés-Cano E; Marchi R
    BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms influencing total and γ' fibrinogen levels and fibrin clot properties in Africans.
    Kotzé RC; Nienaber-Rousseau C; De Lange Z; De Maat MP; Hoekstra T; Pieters M
    Br J Haematol; 2015 Jan; 168(1):102-12. PubMed ID: 25156046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride concentration and waist circumference influence alcohol-related plasminogen activator inhibitor-1 activity increase in black South Africans.
    Pieters M; de Lange Z; Hoekstra T; Ellis SM; Kruger A
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):736-43. PubMed ID: 20881480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 Diabetes.
    Bryk AH; Konieczynska M; Rostoff P; Broniatowska E; Hohendorff J; Malecki MT; Undas A
    Thromb Haemost; 2019 Feb; 119(2):213-222. PubMed ID: 30605917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects.
    Siudut J; Iwaniec T; Plens K; Pieters M; Undas A
    Thromb Res; 2021 Jan; 197():1-7. PubMed ID: 33157491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certain Associations Between Iron Biomarkers and Total and γ' Fibrinogen and Plasma Clot Properties Are Mediated by Fibrinogen Genotypes.
    Rautenbach PH; Nienaber-Rousseau C; de Lange-Loots Z; Pieters M
    Front Nutr; 2021; 8():720048. PubMed ID: 34447779
    [No Abstract]   [Full Text] [Related]  

  • 15. Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis.
    Sidelmann JJ; Gram JB; Rasmussen JJ; Kistorp C
    Semin Thromb Hemost; 2021 Feb; 47(1):11-17. PubMed ID: 33017849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer relates positively with increased blood pressure in black South Africans: the SABPA study.
    Lammertyn L; Schutte AE; Pieters M; Schutte R
    Thromb Res; 2014 Jun; 133(6):1152-7. PubMed ID: 24713108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
    Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.
    Alzahrani SH; Hess K; Price JF; Strachan M; Baxter PD; Cubbon R; Phoenix F; Gamlen T; Ariëns RA; Grant PJ; Ajjan RA
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2282-7. PubMed ID: 22996148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.